APOE ε4 and Intracerebral Hemorrhage in Patients With Brain Arteriovenous Malformation

被引:1
|
作者
Renedo, Daniela [1 ,2 ]
Rivier, Cyprien A. [1 ]
Koo, Andrew B. [2 ]
Sujijantarat, Nanthiya [2 ]
Clocchiatti-Tuozzo, Santiago [1 ,3 ]
Wu, Kane [1 ]
Torres-Lopez, Victor M. [1 ]
Huo, Shufan [1 ]
Gunel, Murat [2 ]
de Havenon, Adam [1 ,3 ]
Sheth, Kevin N. [1 ,2 ,3 ]
Matouk, Charles C. [2 ]
Falcone, Guido J. [1 ,3 ]
机构
[1] Yale Sch Med, Dept Neurol, 15 York St,LLCI Room 1004D,POB 208018, New Haven, CT 06510 USA
[2] Yale Sch Med, Dept Neurosurg, New Haven, CT USA
[3] Yale Ctr Brain & Mind Hlth, New Haven, CT USA
基金
美国国家卫生研究院;
关键词
D O I
10.1001/jamanetworkopen.2023.55368
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Intracerebral hemorrhage (ICH) is a serious complication of brain arteriovenous malformation (AVM). Apolipoprotein E (APOE) epsilon 4 is a well-known genetic risk factor for ICH among persons without AVM, and cerebral amyloid angiopathy is a vasculopathy frequently observed in APOE epsilon 4 carriers that may increase the risk of ICH. Objective To assess whether APOE epsilon 4 is associated with a higher risk of ICH in patients with a known AVM. Design, Setting, and Participants This cross-sectional study including 412 participants was conducted in 2 stages (discovery and replication) using individual-level data from the UK Biobank (released March 2012 and last updated October 2023) and the All of Us Research Program (commenced on May 6, 2018, with its latest update provided in October 2023). The occurrence of AVM and ICH was ascertained at the time of enrollment using validated International Classification of Diseases, Ninth Revision and Tenth Revision, codes. Genotypic data on the APOE variants rs429358 and rs7412 were used to ascertain the epsilon status. Main Outcomes and Measures For each study, the association between APOE epsilon 4 variants and ICH risk was assessed among patients with a known AVM by using multivariable logistic regression. Results The discovery phase included 253 UK Biobank participants with known AVM (mean [SD] age, 56.6 [8.0] years, 119 [47.0%] female), of whom 63 (24.9%) sustained an ICH. In the multivariable analysis of 240 participants of European ancestry, APOE epsilon 4 was associated with a higher risk of ICH (odds ratio, 4.58; 95% CI, 2.13-10.34; P < .001). The replication phase included 159 participants with known AVM enrolled in All of Us (mean [SD] age, 57.1 [15.9] years; 106 [66.7%] female), of whom 29 (18.2%) sustained an ICH. In multivariable analysis of 101 participants of European ancestry, APOE epsilon 4 was associated with higher risk of ICH (odds ratio, 4.52; 95% CI, 1.18-19.38; P = .03). Conclusions and Relevance The results of this cross-sectional study of patients from the UK Biobank and All of Us suggest that information on APOE epsilon 4 status may help identify patients with brain AVM who are at particularly high risk of ICH and that cerebral amyloid angiopathy should be evaluated as a possible mediating mechanism of the observed association.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Polymorphisms In DNA Methylated Genes And Risk Of Intracranial Hemorrhage In Brain Arteriovenous Malformation Patients
    Zaw, Thinzar
    Weinsheimer, Shantel
    Nelson, Jeffrey
    McCulloch, Charles
    Zaroff, Jonathan
    Kim, Helen
    STROKE, 2023, 54
  • [32] Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population
    Halim, AX
    Johnston, SC
    Singh, V
    McCulloch, CE
    Bennett, JP
    Achrol, AS
    Sidney, S
    Young, WL
    STROKE, 2004, 35 (07) : 1697 - 1702
  • [33] Racial/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients
    Kim, Helen
    Sidney, Stephen
    Johnston, S. Claiborne
    Ko, Nerissa U.
    Singh, Vineeta
    Achrol, Achal S.
    Poon, K. Y. Trudy
    McCulloch, Charles E.
    Young, William L.
    JOURNAL OF NEUROSURGERY, 2007, 106 (05) : A948 - A949
  • [34] DURAL ARTERIOVENOUS MALFORMATION CAUSING BRAIN-STEM HEMORRHAGE
    BRENNAN, J
    MORGAN, MK
    JOURNAL OF CLINICAL NEUROSCIENCE, 1995, 2 (03) : 271 - 273
  • [35] Predictors of intracranial hemorrhage volume and distribution in brain arteriovenous malformation
    Yu, Jay F.
    Nicholson, Andrew D.
    Nelson, Jeffrey
    Alexander, Matthew D.
    Tse, Stephanie H.
    Hetts, Steven W.
    Hemphill, J. Claude, III
    Kim, Helen
    Cooke, Daniel L.
    INTERVENTIONAL NEURORADIOLOGY, 2018, 24 (02) : 183 - 188
  • [36] Morbidity after Hemorrhage in Children with Untreated Brain Arteriovenous Malformation
    Ma, Li
    Kim, Helen
    Chen, Xiao-Lin
    Wu, Chun-Xue
    Ma, Jun
    Su, Hua
    Zhao, Yuanli
    CEREBROVASCULAR DISEASES, 2017, 43 (5-6) : 231 - 241
  • [37] Molecular Signature of Brain Arteriovenous Malformation Hemorrhage: A Systematic Review
    Germans, Menno R.
    Sun, Wenhua
    Sebok, Martina
    Keller, Annika
    Regli, Luca
    Germans, Menno R.
    WORLD NEUROSURGERY, 2022, 157 : 143 - 151
  • [38] Outcomes After Intracerebral Hemorrhage in Patients With Arteriovenous Malformations
    Murthy, Santosh
    Merkler, Alexander E.
    Omran, Setareh S.
    Gialdini, Gino
    Iadecola, Costantino
    Navi, Babak B.
    Kamel, Hooman
    STROKE, 2017, 48
  • [39] Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation
    Morgan, M
    Sekhon, L
    Rahman, Z
    Dandie, G
    STROKE, 1998, 29 (09) : 2001 - 2001
  • [40] Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation
    Hartmann, A
    Mast, H
    Mohr, JP
    Koennecke, HC
    Osipov, A
    Pile-Spellman, J
    Duong, DH
    Young, WL
    STROKE, 1998, 29 (05) : 931 - 934